Qvt Financial LP Clovis Oncology, Inc. Call Options Transaction History

Qvt Financial LP

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.96 $63,000 - $296,000	100,000 Added 20.0%	600,000 $1.08 Million
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $715,000 - $1.57 Million	500,000 New	500,000 $1.01 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Qvt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Qvt Financial LP with notifications on news.